Intuitive President David Rosa Named to Company’s Board

Intuitive Surgical has appointed President David J. Rosa to its Board of Directors.
 
Rosa joins Intuitive CEO Gary S. Guthart, Ph.D., as one of two company executives on the board. As president, Rosa manages Intuitive’s core business operations, which is balanced by Guthart’s focus on enterprise strategy and corporate functions. Together, Rosa and Guthart represent more than 50 years of Intuitive leadership.
 
Intuitive appointed Rosa as president in May 2023. Over his nearly 27-year tenure with the company, Rosa has held leadership positions across multiple functions including product development, commercial operations, and clinical and regulatory affairs, and his executive leadership has spanned more than a decade.
 
Currently, Rosa oversees Intuitive’s business unit, quality, regulatory, manufacturing, and commercial operations. He also serves as board chairman of Intuitive-Fosun, the joint venture between Intuitive and Fosun Pharma, based in Shanghai, China.
 
“Intuitive’s Board leadership will benefit from Dave Rosa’s deep and broad experience across the company, as well as his commitment to excellence in operations, innovation, and customer collaboration,” Guthart said. “Balancing strategy and operations on the Board of Directors adds an important dimension to Intuitive stewardship.”
 
A holder of multiple patents, Rosa earned a bachelor of science degree in mechanical engineering from California Polytechnic University at San Luis Obispo and a master of science degree in mechanical engineering from Stanford University. He also serves on the board of Kardium Inc., where he is a member of the compensation committee.
 
Rosa fills a newly created seat with the Intuitive board expansion from 11 to 12 directors.
 
Headquartered in Sunnyvale, Calif., Intuitive is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system.